Innovation Pharmaceuticals's market cap is currently $52.07K. The company's EPS TTM is $-0.005; its P/E ratio is ―; Innovation Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Jun 22	Jun 21	Jun 20	Jun 19
Income Statement
Total Revenue	$ 0.00	$ 18.00K	$ 0.00	$ 423.00K	$ 0.00
Gross Profit	$ -373.00K	$ -364.00K	$ -378.00K	$ 423.00K	$ -371.00K
Operating Income	$ -3.11M	$ -6.92M	$ -9.02M	$ -4.63M	$ -6.45M
EBITDA	$ -2.74M	$ -6.54M	$ -8.64M	$ -6.01M	$ -6.11M
Net Income	$ -3.17M	$ -7.16M	$ -18.73M	$ -7.01M	$ -9.07M
Balance Sheet
Cash & Short-Term Investments	$ 1.52M	$ 3.81M	$ 10.19M	$ 6.02M	$ 579.00K
Total Assets	$ 7.52M	$ 10.38M	$ 14.30M	$ 9.25M	$ 4.05M
Total Debt	$ 268.00K	$ 502.00K	$ 1.87M	$ 2.46M	$ 1.92M
Net Debt	$ -1.25M	$ -3.31M	$ -8.32M	$ -3.56M	$ 1.34M
Total Liabilities	$ 5.48M	$ 5.65M	$ 6.79M	$ 7.79M	$ 8.18M
Stockholders' Equity	$ 2.04M	$ 4.73M	$ 7.51M	$ 1.46M	$ -4.13M
Cash Flow
Free Cash Flow	$ -2.17M	$ -6.36M	$ -9.57M	$ -4.25M	$ -6.42M
Operating Cash Flow	$ -2.11M	$ -6.28M	$ -9.49M	$ -4.16M	$ -6.33M
Investing Cash Flow	$ -60.00K	$ -4.08M	$ -72.00K	$ -91.00K	$ -46.00K
Financing Cash Flow	$ -123.00K	$ 3.97M	$ 13.74M	$ 9.69M	$ 4.53M

Currency in USD

Innovation Pharmaceuticals Earnings and Revenue History

Income Statement >

Innovation Pharmaceuticals Debt to Assets

Balance Sheet >

Innovation Pharmaceuticals Cash Flow

Cash Flow >

Innovation Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing